{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T18:17:04Z","timestamp":1770315424906,"version":"3.49.0"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T00:00:00Z","timestamp":1769990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"IDB RAS Government basic research program","award":["0088-2024-0010"],"award-info":[{"award-number":["0088-2024-0010"]}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["SARSTUBVAR"],"award-info":[{"award-number":["SARSTUBVAR"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-06029-5","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T08:06:20Z","timestamp":1770019580000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interaction between HIV-1 Tat and EBV Zta favours immune escape of B cells by downregulating HLA-ABC expression"],"prefix":"10.1007","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7162-074X","authenticated-orcid":false,"given":"Anna","family":"Shmakova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Schwager","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Tsimailo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emile","family":"Clerf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yana","family":"Kozhevnikova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"G\u00e9rard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Boutboul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Oksenhendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Habib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Drouet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Germini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3101-7043","authenticated-orcid":false,"given":"Yegor","family":"Vassetzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"6029_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/QAD.0b013e3283324283","volume":"24","author":"HIV-CAUSAL Collaboration","year":"2010","unstructured":"Collaboration HIV-CAUSAL, Ray M, Logan R, Sterne JAC, Hern\u00e1ndez-D\u00edaz S, Robins JM, Sabin C, Bansi L, van Sighem A, de Wolf F et al (2010) The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS 24:123\u2013137. https:\/\/doi.org\/10.1097\/QAD.0b013e3283324283","journal-title":"AIDS"},{"key":"6029_CR2","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","volume":"33","author":"AE Coghill","year":"2015","unstructured":"Coghill AE, Shiels MS, Suneja G, Engels EA (2015) Elevated cancer-specific mortality among HIV-infected patients in the united States. J Clin Oncology: Official J Am Soc Clin Oncol 33:2376\u20132383. https:\/\/doi.org\/10.1200\/JCO.2014.59.5967","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"key":"6029_CR3","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1002\/ijc.32730","volume":"146","author":"A Shmakova","year":"2020","unstructured":"Shmakova A, Germini D, Vassetzky Y (2020) HIV-1, HAART and cancer: a complex relationship. Int J Cancer 146:2666\u20132679. https:\/\/doi.org\/10.1002\/ijc.32730","journal-title":"Int J Cancer"},{"key":"6029_CR4","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1038\/s41467-020-17696-2","volume":"11","author":"N Sallah","year":"2020","unstructured":"Sallah N, Miley W, Labo N, Carstensen T, Fatumo S, Gurdasani D, Pollard MO, Dilthey AT, Mentzer AJ, Marshall V et al (2020) Distinct genetic architectures and environmental factors associate with host response to the \u03932-herpesvirus infections. Nat Commun 11:3849. https:\/\/doi.org\/10.1038\/s41467-020-17696-2","journal-title":"Nat Commun"},{"key":"6029_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12250-018-0028-z","volume":"33","author":"Y Yan","year":"2018","unstructured":"Yan Y, Ren Y, Chen R, Hu J, Ji Y, Yang J, Shen J, Hu L, Pei H, Wang J et al (2018) Evaluation of Epstein-Barr virus salivary shedding in HIV\/AIDS patients and HAART use: a retrospective cohort study. Virol Sin 33:227\u2013233. https:\/\/doi.org\/10.1007\/s12250-018-0028-z","journal-title":"Virol Sin"},{"key":"6029_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/jmv.1890360112","volume":"36","author":"A Quesnel","year":"1992","unstructured":"Quesnel A, Pozzetto B, Touraine F, Moja P, Lucht F, De The G, Touraine JL, Gaudin O, Genin C (1992) Antibodies to Epstein-Barr virus and cytomegalovirus in relation to CD4 cell number in human immunodeficiency virus 1 infection. J Med Virol 36:60\u201364. https:\/\/doi.org\/10.1002\/jmv.1890360112","journal-title":"J Med Virol"},{"key":"6029_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI (2000) Epstein\u2013Barr virus infection. N Engl J Med 343:481\u2013492. https:\/\/doi.org\/10.1056\/NEJM200008173430707","journal-title":"N Engl J Med"},{"key":"6029_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/rmv.441","volume":"15","author":"T Tsurumi","year":"2005","unstructured":"Tsurumi T, Fujita M, Kudoh A (2005) Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol 15:3\u201315","journal-title":"Rev Med Virol"},{"key":"6029_CR9","doi-asserted-by":"crossref","unstructured":"Cohen JI, Fauci AS, Varmus H, Nabel GJ (2011) Epstein-Barr Virus: An Important Vaccine Target for Cancer Prevention. In Proceedings of the Science Translational Medicine; American Association for the Advancement of Science, November 2 ; Vol. 3, p. 107","DOI":"10.1126\/scitranslmed.3002878"},{"key":"6029_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/1348-0421.12155","volume":"58","author":"T Murata","year":"2014","unstructured":"Murata T (2014) Regulation of Epstein-Barr virus reactivation from latency. Microbiol Immunol 58:307\u2013317","journal-title":"Microbiol Immunol"},{"key":"6029_CR11","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1517\/14712598.6.11.1193","volume":"6","author":"SB Pattle","year":"2006","unstructured":"Pattle SB, Farrell PJ (2006) The role of Epstein\u2013Barr virus in cancer. Expert Opin Biol Ther 6:1193\u20131205. https:\/\/doi.org\/10.1517\/14712598.6.11.1193","journal-title":"Expert Opin Biol Ther"},{"key":"6029_CR12","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1146\/annurev.pathol.1.110304.100209","volume":"1","author":"JL Kutok","year":"2006","unstructured":"Kutok JL, Wang F (2006) Spectrum of Epstein-Barr virus-associated diseases. Annu Rev Pathol 1:375\u2013404. https:\/\/doi.org\/10.1146\/annurev.pathol.1.110304.100209","journal-title":"Annu Rev Pathol"},{"key":"6029_CR13","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1126\/science.abm7930","volume":"375","author":"WH Robinson","year":"2022","unstructured":"Robinson WH, Steinman L (2022) Epstein-Barr virus and multiple sclerosis. Science 375:264\u2013265. https:\/\/doi.org\/10.1126\/science.abm7930","journal-title":"Science"},{"key":"6029_CR14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/QAD.0000000000002484","volume":"34","author":"S Gianella","year":"2020","unstructured":"Gianella S, Moser C, Vitomirov A, McKhann A, Layman L, Scott B, Caballero G, Lada S, Bosch RJ, Hoenigl M et al (2020) Presence of asymptomatic CMV and EBV DNA in blood of persons with HIV starting antiretroviral therapy are associated with Non-AIDS clinical events. AIDS 34:849\u2013857. https:\/\/doi.org\/10.1097\/QAD.0000000000002484","journal-title":"AIDS"},{"key":"6029_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/jmv.10080","volume":"67","author":"CE O\u2019Sullivan","year":"2002","unstructured":"O\u2019Sullivan CE, Peng R, Cole KS, Montelaro RC, Sturgeon T, Jenson HB, Ling PD (2002) Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART. J Med Virol 67:320\u2013326. https:\/\/doi.org\/10.1002\/jmv.10080","journal-title":"J Med Virol"},{"key":"6029_CR16","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/jmv.23858","volume":"86","author":"DE Ouedraogo","year":"2014","unstructured":"Ouedraogo DE, Bollore K, Viljoen J, Foulongne V, Reynes J, Cartron G, Vendrell J-P, Van de Perre P, Tuaillon E (2014) Comparison of EBV DNA viral load in whole blood, plasma, B-cells and B-cell culture supernatant. J Med Virol 86:851\u2013856. https:\/\/doi.org\/10.1002\/jmv.23858","journal-title":"J Med Virol"},{"key":"6029_CR17","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1086\/378808","volume":"37","author":"PD Ling","year":"2003","unstructured":"Ling PD, Vilchez RA, Keitel WA, Poston DG, Peng RS, White ZS, Visnegarwala F, Lewis DE, Butel JS (2003) Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. Clin Infect Dis 37:1244\u20131249. https:\/\/doi.org\/10.1086\/378808","journal-title":"Clin Infect Dis"},{"key":"6029_CR18","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1128\/jcm.29.6.1215-1220.1991","volume":"29","author":"MA Rahman","year":"1991","unstructured":"Rahman MA, Kingsley LA, Atchison RW, Belle S, Breinig MC, Ho M, Rinaldo CR (1991) Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus. J Clin Microbiol 29:1215\u20131220. https:\/\/doi.org\/10.1128\/jcm.29.6.1215-1220.1991","journal-title":"J Clin Microbiol"},{"key":"6029_CR19","doi-asserted-by":"publisher","unstructured":"Shannon-Lowe C, Rickinson AB, Bell AI (2017) Epstein-Barr Virus-Associated lymphomas. Philosophical Trans Royal Soc B: Biol Sci 372(1732):20160271 https:\/\/doi.org\/10.1098\/rstb.2016.0271}","DOI":"10.1098\/rstb.2016.0271"},{"key":"6029_CR20","doi-asserted-by":"publisher","DOI":"10.26508\/LSA.202000640","author":"D McHugh","year":"2020","unstructured":"McHugh D, Myburgh R, Caduff N, Spohn M, Kok YL, Keller CW, Murer A, Chatterjee B, R\u00fchl J, Engelmann C (2020) EBV renders B cells susceptible to HIV-1 in humanized mice. Life Sci Alliance. https:\/\/doi.org\/10.26508\/LSA.202000640","journal-title":"Life Sci Alliance"},{"key":"6029_CR21","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-5-S3-S11","volume":"5","author":"F Xu","year":"2011","unstructured":"Xu F, Zhao C, Li Y, Li J, Deng Y, Shi T (2011) Exploring virus relationships based on virus-Host Protein-Protein interaction network. BMC Syst Biol 5:S11. https:\/\/doi.org\/10.1186\/1752-0509-5-S3-S11","journal-title":"BMC Syst Biol"},{"key":"6029_CR22","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/nrmicro2452","volume":"8","author":"VI Agol","year":"2010","unstructured":"Agol VI, Gmyl AP (2010) Viral security proteins: counteracting host defences. Nat Rev Microbiol 8:867\u2013878","journal-title":"Nat Rev Microbiol"},{"key":"6029_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cell.2020.06.023","volume":"182","author":"X Liu","year":"2020","unstructured":"Liu X, Hong T, Parameswaran S, Ernst K, Marazzi I, Weirauch MT, Fuxman Bass JI (2020) Human virus transcriptional regulators. Cell 182:24\u201337. https:\/\/doi.org\/10.1016\/j.cell.2020.06.023","journal-title":"Cell"},{"key":"6029_CR24","doi-asserted-by":"crossref","unstructured":"Germini D, Sall FB, Shmakova A, Wiels J, Dokudovskaya S, Drouet E, Vassetzky Y (2020) Oncogenic Properties of the Ebv Zebra Protein. Cancers 12, 1\u201326","DOI":"10.3390\/cancers12061479"},{"key":"6029_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2031","author":"MA Kurnaeva","year":"2019","unstructured":"Kurnaeva MA, Sheval EV, Musinova YR, Vassetzky YS (2019) Tat basic domain: a \u201cSwiss army knife\u201d of HIV\u20101 Tat? Rev Med Virol. https:\/\/doi.org\/10.1002\/rmv.2031","journal-title":"Rev Med Virol"},{"key":"6029_CR26","doi-asserted-by":"publisher","first-page":"20224","DOI":"10.1074\/jbc.M110.101550","volume":"285","author":"R Rothe","year":"2010","unstructured":"Rothe R, Liguori L, Villegas-Mendez A, Marques B, Grunwald D, Drouet E, Lenormand JL (2010) Characterization of the Cell-Penetrating properties of the Epstein-Barr virus ZEBRA Trans-Activator. J Biol Chem 285:20224\u201320233. https:\/\/doi.org\/10.1074\/jbc.M110.101550","journal-title":"J Biol Chem"},{"key":"6029_CR27","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1182\/blood-2003-08-2928","volume":"103","author":"A Poggi","year":"2004","unstructured":"Poggi A, Carosio R, Fenoglio D, Brenci S, Murdaca G, Setti M, Indiveri F, Scabini S, Ferrero E, Zocchi MR (2004) Migration of V\u03b41 and V\u03b42 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients: competition by HIV-1 Tat. Blood 103:2205\u20132213. https:\/\/doi.org\/10.1182\/blood-2003-08-2928","journal-title":"Blood"},{"key":"6029_CR28","doi-asserted-by":"publisher","first-page":"10479","DOI":"10.1038\/s41598-017-09798-7","volume":"7","author":"M Habib","year":"2017","unstructured":"Habib M, Buisson M, Lupo J, Agbalika F, Soci\u00e9 G, Germi R, Baccard M, Imbert-Marcille B-M, Dantal J, Morand P et al (2017) Lytic EBV infection investigated by detection of soluble Epstein-Barr virus ZEBRA in the serum of patients with PTLD. Sci Rep 7:10479. https:\/\/doi.org\/10.1038\/s41598-017-09798-7","journal-title":"Sci Rep"},{"key":"6029_CR29","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.expneurol.2004.11.019","volume":"193","author":"WA Banks","year":"2005","unstructured":"Banks WA, Robinson SM, Nath A (2005) Permeability of the Blood-Brain barrier to HIV-1 Tat. Exp Neurol 193:218\u2013227. https:\/\/doi.org\/10.1016\/j.expneurol.2004.11.019","journal-title":"Exp Neurol"},{"key":"6029_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep11322","author":"S Li","year":"2015","unstructured":"Li S, Hou H, Mori T, Sawmiller D, Smith A, Tian J, Wang Y, Giunta B, Sanberg PR, Zhang S (2015) Swedish mutant APP-based BACE1 binding site peptide reduces APP \u03b2-cleavage and cerebral A\u03b2 levels in Alzheimer\u2019s mice. Sci Rep. https:\/\/doi.org\/10.1038\/srep11322","journal-title":"Sci Rep"},{"key":"6029_CR31","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00018-015-2077-x","volume":"73","author":"YR Musinova","year":"2016","unstructured":"Musinova YR, Sheval EV, Dib C, Germini D, Vassetzky YS (2016) Functional roles of HIV-1 Tat protein in the nucleus. Cell Mol Life Sci 73:589\u2013601. https:\/\/doi.org\/10.1007\/s00018-015-2077-x","journal-title":"Cell Mol Life Sci"},{"key":"6029_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.106994","volume":"142","author":"A Shmakova","year":"2024","unstructured":"Shmakova A, Tsimailo I, Kozhevnikova Y, G\u00e9rard L, Boutboul D, Oksenhendler E, Tuaillon E, Rivault A, Germini D, Vassetzky Y (2024) HIV-1 Tat is present in the serum of people living with HIV-1 despite viral suppression. Int J Infect Dis 106994. https:\/\/doi.org\/10.1016\/j.ijid.2024.106994","journal-title":"Int J Infect Dis"},{"key":"6029_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29423","volume":"96","author":"A Shmakova","year":"2024","unstructured":"Shmakova A, Hugot C, Kozhevnikova Y, Schwager (Karpukhina) A, Tsimailo I, G\u00e9rard L, Boutboul D, Oksenhendler E, Szewczyk-Roszczenko O, Roszczenko P (2024) Chronic HIV\u20101 Tat action induces HLA\u2010DR downregulation in B cells: a mechanism for lymphoma immune escape in people living with HIV. J Med Virol 96:e29423. https:\/\/doi.org\/10.1002\/jmv.29423","journal-title":"J Med Virol"},{"issue":"Suppl 2","key":"6029_CR34","doi-asserted-by":"publisher","first-page":"S145","DOI":"10.1097\/QAD.0000000000002268","volume":"33","author":"LJ Henderson","year":"2019","unstructured":"Henderson LJ, Johnson TP, Smith BR, Reoma LB, Santamaria UA, Bachani M, Demarino C, Barclay RA, Snow J, Sacktor N et al (2019) Presence of Tat and Transactivation Response Element in Spinal Fluid despite Antiretroviral Therapy. AIDS 33(Suppl 2):S145\u2013S157. https:\/\/doi.org\/10.1097\/QAD.0000000000002268","journal-title":"AIDS"},{"key":"6029_CR35","doi-asserted-by":"publisher","first-page":"e26894","DOI":"10.1371\/journal.pone.0026894","volume":"6","author":"C Marban","year":"2011","unstructured":"Marban C, Su T, Ferrari R, Li B, Vatakis D, Pellegrini M, Zack JA, Rohr O, Kurdistani SK (2011) Genome-wide binding map of the HIV-1 Tat protein to the human genome. PLoS One 6:e26894. https:\/\/doi.org\/10.1371\/journal.pone.0026894","journal-title":"PLoS One"},{"key":"6029_CR36","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1101\/gad.11.20.2633","volume":"11","author":"HSY Mancebo","year":"1997","unstructured":"Mancebo HSY, Lee G, Flygare J, Tomassini J, Luu P, Zhu Y, Peng J, Blau C, Hazuda D, Price D et al (1997) P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev 11:2633\u20132644. https:\/\/doi.org\/10.1101\/gad.11.20.2633","journal-title":"Genes Dev"},{"key":"6029_CR37","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1371\/journal.pbio.0030044","volume":"3","author":"T Raha","year":"2005","unstructured":"Raha T, Cheng SWG, Green MR (2005) HIV-1 Tat stimulates transcription complex assembly through recruitment of TBP in the absence of TAFs. PLoS Biol 3:e44. https:\/\/doi.org\/10.1371\/journal.pbio.0030044","journal-title":"PLoS Biol"},{"key":"6029_CR38","doi-asserted-by":"publisher","first-page":"e08955","DOI":"10.7554\/eLife.08955","volume":"4","author":"JE Reeder","year":"2015","unstructured":"Reeder JE, Kwak Y-TT, McNamara RP, Forst CV, D\u2019Orso I, D\u2019Orso I (2015) HIV Tat controls RNA polymerase II and the epigenetic landscape to transcriptionally reprogram target immune cells. Elife 4:e08955. https:\/\/doi.org\/10.7554\/eLife.08955","journal-title":"Elife"},{"key":"6029_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/vir.0.016303-0","volume":"91","author":"B Romani","year":"2010","unstructured":"Romani B, Engelbrecht S, Glashoff RH (2010) Functions of tat: the versatile protein of human immunodeficiency virus type 1. J Gen Virol 91:1\u201312. https:\/\/doi.org\/10.1099\/vir.0.016303-0","journal-title":"J Gen Virol"},{"key":"6029_CR40","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1073\/pnas.82.12.4085","volume":"82","author":"J Countryman","year":"1985","unstructured":"Countryman J, Miller G (1985) Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc Natl Acad Sci U S A 82:4085\u20134089. https:\/\/doi.org\/10.1073\/pnas.82.12.4085","journal-title":"Proc Natl Acad Sci U S A"},{"key":"6029_CR41","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1093\/emboj\/19.12.3080","volume":"19","author":"R Feederle","year":"2000","unstructured":"Feederle R, Kost M, Baumann M, Janz A, Drouet E, Hammerschmidt W, Delecluse HJ (2000) The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19:3080\u20133089. https:\/\/doi.org\/10.1093\/emboj\/19.12.3080","journal-title":"EMBO J"},{"key":"6029_CR42","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.molcel.2006.01.006","volume":"21","author":"C Petosa","year":"2006","unstructured":"Petosa C, Morand P, Baudin F, Moulin M, Artero JB, M\u00fcller CW (2006) Structural basis of lytic cycle activation by the Epstein-Barr virus ZEBRA protein. Mol Cell 21:565\u2013572. https:\/\/doi.org\/10.1016\/j.molcel.2006.01.006","journal-title":"Mol Cell"},{"key":"6029_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000356","author":"SJ Dickerson","year":"2009","unstructured":"Dickerson SJ, Xing Y, Robinson AR, Seaman WT, Gruffat H, Kenney SC (2009) Methylation-dependent binding of the Epstein-Barr virus BZLF1 protein to viral promoters. PLoS Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1000356","journal-title":"PLoS Pathog"},{"key":"6029_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0025922","volume":"6","author":"K Flower","year":"2011","unstructured":"Flower K, Thomas D, Heather J, Ramasubramanyan S, Jones S, Sinclair AJ (2011) Epigenetic control of viral life-cycle by a DNA-methylation dependent transcription factor. PLoS One 6:25922. https:\/\/doi.org\/10.1371\/journal.pone.0025922","journal-title":"PLoS One"},{"key":"6029_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1001114","author":"M Bergbauer","year":"2010","unstructured":"Bergbauer M, Kalla M, Schmeinck A, G\u00f6bel C, Rothbauer U, Eck S, Benet-Pag\u00e9s A, Strom TM, Hammerschmidt W (2010) Cpg-methylation regulates a class of Epstein-Barr virus promoters. PLoS Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1001114","journal-title":"PLoS Pathog"},{"key":"6029_CR46","doi-asserted-by":"publisher","first-page":"7976","DOI":"10.1128\/jvi.00770-12","volume":"86","author":"S-D Ma","year":"2012","unstructured":"Ma S-D, Yu X, Mertz JE, Gumperz JE, Reinheim E, Zhou Y, Tang W, Burlingham WJ, Gulley ML, Kenney SC (2012) An Epstein-Barr virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model. J Virol 86:7976\u20137987. https:\/\/doi.org\/10.1128\/jvi.00770-12","journal-title":"J Virol"},{"key":"6029_CR47","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/ijc.10372","volume":"99","author":"SA Xue","year":"2002","unstructured":"Xue SA, Labrecque LG, Lu QL, Ong SK, Lampert IA, Kazembe P, Molyneux E, Broadhead RL, Borgstein E, Griffin BE (2002) Promiscuous expression of Epstein-Barr virus genes in burkitt\u2019s lymphoma from the central African country Malawi. Int J Cancer 99:635\u2013643. https:\/\/doi.org\/10.1002\/ijc.10372","journal-title":"Int J Cancer"},{"key":"6029_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/hon.2465","volume":"36","author":"M Cohen","year":"2018","unstructured":"Cohen M, Vistarop AG, Huaman F, Narbaitz M, Metrebian F, De Matteo E, Preciado MV, Chabay PA (2018) Epstein-Barr virus lytic cycle involvement in diffuse large B cell lymphoma. Hematol Oncol 36:98\u2013103. https:\/\/doi.org\/10.1002\/hon.2465","journal-title":"Hematol Oncol"},{"key":"6029_CR49","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1128\/jvi.74.6.2793-2803.2000","volume":"74","author":"S-A Xue","year":"2000","unstructured":"Xue S-A, Lu Q-L, Poulsom R, Karran L, Jones MD, Griffin BE (2000) Expression of two related viral early genes in Epstein-Barr Virus-Associated tumors. J Virol 74:2793\u20132803. https:\/\/doi.org\/10.1128\/jvi.74.6.2793-2803.2000","journal-title":"J Virol"},{"key":"6029_CR50","doi-asserted-by":"publisher","first-page":"13267","DOI":"10.1128\/jvi.77.24.13267-13274.2003","volume":"77","author":"J Huang","year":"2003","unstructured":"Huang J, Chen H, Hutt-Fletcher L, Ambinder RF, Hayward SD (2003) Lytic viral replication as a contributor to thedetection of Epstein-Barr virus in breastcancer. J Virol 77:13267\u201313274. https:\/\/doi.org\/10.1128\/jvi.77.24.13267-13274.2003","journal-title":"J Virol"},{"key":"6029_CR51","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/ijc.30418","volume":"140","author":"O Ramayanti","year":"2017","unstructured":"Ramayanti O, Juwana H, Verkuijlen SAMW, Adham M, Pegtel MD, Greijer AE, Middeldorp JM (2017) Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin. Int J Cancer 140:149\u2013162. https:\/\/doi.org\/10.1002\/ijc.30418","journal-title":"Int J Cancer"},{"key":"6029_CR52","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri3084","volume":"11","author":"J Neefjes","year":"2011","unstructured":"Neefjes J, Jongsma MLM, Paul P, Bakke O (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11:823\u2013836. https:\/\/doi.org\/10.1038\/nri3084","journal-title":"Nat Rev Immunol"},{"key":"6029_CR53","doi-asserted-by":"publisher","first-page":"200348","DOI":"10.1098\/rsob.200348","volume":"11","author":"M Padariya","year":"2021","unstructured":"Padariya M, Kalathiya U, Mikac S, Dziubek K, Tovar Fernandez MC, Sroka E, Fahraeus R, Sznarkowska A (2021) Viruses, cancer and non-self recognition. Open Biol 11:200348. https:\/\/doi.org\/10.1098\/rsob.200348","journal-title":"Open Biol"},{"key":"6029_CR54","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1134\/s1062360419050060","volume":"50","author":"MA Gorbacheva","year":"2019","unstructured":"Gorbacheva MA, Tikhomirova MA, Potashnikova DM, Akbay B, Sheval EV, Musinova YR (2019) Production of stable cell lines on the basis of the cultured RPMI 8866 B-cells with constant and inducible expression of the human immunodeficiency virus Tat protein. Russ J Dev Biol 50:275\u2013280. https:\/\/doi.org\/10.1134\/s1062360419050060","journal-title":"Russ J Dev Biol"},{"key":"6029_CR55","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28633","volume":"95","author":"FB Sall","year":"2023","unstructured":"Sall FB, Shmakova A, Karpukhina A, Tsfasman T, Lomov N, Canoy RJ, Boutboul D, Oksenhendler E, Toure AO, Lipinski M et al (2023) Epstein\u2009\u2212\u2009Barr virus reactivation induces MYC-IGH spatial proximity and t(8;14) in B cells. J Med Virol 95:e28633. https:\/\/doi.org\/10.1002\/jmv.28633","journal-title":"J Med Virol"},{"key":"6029_CR56","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cac2.12370","volume":"43","author":"A Shmakova","year":"2023","unstructured":"Shmakova A, Lomov N, Viushkov V, Tsfasman T, Kozhevnikova Y, Sokolova D, Pokrovsky V, Syrkina M, Germini D, Rubtsov M et al (2023) Cell models with inducible oncogenic translocations allow to evaluate the potential of drugs to favor secondary translocations. Cancer Commun 43:154\u2013158. https:\/\/doi.org\/10.1002\/cac2.12370","journal-title":"Cancer Commun"},{"key":"6029_CR57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1385\/1-59259-227-9:203","volume":"174","author":"V Levitsky","year":"2001","unstructured":"Levitsky V, Frisan T, Masucci M (2001) Generation of polyclonal EBV-specific CTL cultures and clones. Methods Mol Biol 174:203\u2013208. https:\/\/doi.org\/10.1385\/1-59259-227-9:203","journal-title":"Methods Mol Biol"},{"key":"6029_CR58","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2220\/biomedres.32.159","volume":"32","author":"Y Nakagawa","year":"2011","unstructured":"Nakagawa Y, Watari E, Shimizu M, Takahashi H (2011) One-step simple assay to determine antigen-specific cytotoxic activities by single-color flow cytometry. Biomed Res 32:159\u2013166. https:\/\/doi.org\/10.2220\/biomedres.32.159","journal-title":"Biomed Res"},{"key":"6029_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-020-00194-x","author":"RJ Canoy","year":"2020","unstructured":"Canoy RJ, Andr\u00e9 F, Shmakova A, Wiels J, Lipinski M, Vassetzky Y, Germini D (2020) Easy and robust electrotransfection protocol for efficient ectopic gene expression and genome editing in human B cells. Gene Ther. https:\/\/doi.org\/10.1038\/s41434-020-00194-x","journal-title":"Gene Ther"},{"key":"6029_CR60","doi-asserted-by":"publisher","first-page":"62","DOI":"10.14440\/jbm.2017.161","volume":"4","author":"S Lapetina","year":"2017","unstructured":"Lapetina S, Gil-Henn HA (2017) Guide to Simple, Direct, and quantitative in vitro binding assays. J Biol Methods 4:62. https:\/\/doi.org\/10.14440\/jbm.2017.161","journal-title":"J Biol Methods"},{"key":"6029_CR61","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.1073\/pnas.0501976102","volume":"102","author":"B Nyfeler","year":"2005","unstructured":"Nyfeler B, Michnick SW, Hauri HP (2005) Capturing protein interactions in the secretory pathway of living cells. Proc Natl Acad Sci USA 102:6350\u20136355. https:\/\/doi.org\/10.1073\/pnas.0501976102","journal-title":"Proc Natl Acad Sci USA"},{"key":"6029_CR62","doi-asserted-by":"publisher","first-page":"e01505","DOI":"10.1128\/JVI.01505-21","volume":"96","author":"MA Kurnaeva","year":"2022","unstructured":"Kurnaeva MA, Zalevsky AO, Arifulin EA, Lisitsyna OM, Tvorogova AV, Shubina MY, Bourenkov GP, Tikhomirova MA, Potashnikova DM, Kachalova AI et al (2022) Molecular coevolution of nuclear and nucleolar localization signals inside the basic domain of HIV-1 Tat. J Virol 96:e01505\u2013e01521. https:\/\/doi.org\/10.1128\/JVI.01505-21","journal-title":"J Virol"},{"key":"6029_CR63","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L et al (2021) ClusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Camb) 2:100141. https:\/\/doi.org\/10.1016\/j.xinn.2021.100141","journal-title":"Innov (Camb)"},{"key":"6029_CR64","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in Real-Time RT-PCR. Nucleic Acids Res 29:e45. https:\/\/doi.org\/10.1093\/nar\/29.9.e45","journal-title":"Nucleic Acids Res"},{"key":"6029_CR65","doi-asserted-by":"publisher","first-page":"research00341","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3:research00341\u2013research003411","journal-title":"Genome Biol"},{"key":"6029_CR66","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1186\/gb-2007-8-2-r19","volume":"8","author":"J Hellemans","year":"2007","unstructured":"Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8:R19. https:\/\/doi.org\/10.1186\/gb-2007-8-2-r19","journal-title":"Genome Biol"},{"key":"6029_CR67","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1038\/s41467-018-05770-9","volume":"9","author":"N Giovannone","year":"2018","unstructured":"Giovannone N, Liang J, Antonopoulos A, Geddes Sweeney J, King SL, Pochebit SM, Bhattacharyya N, Lee GS, Dell A, Widlund HR et al (2018) Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans. Nat Commun 9:3287. https:\/\/doi.org\/10.1038\/s41467-018-05770-9","journal-title":"Nat Commun"},{"key":"6029_CR68","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/glycob\/12.2.111","volume":"12","author":"S Chabot","year":"2002","unstructured":"Chabot S, Kashio Y, Seki M, Shirato Y, Nakamura K, Nishi N, Nakamura T, Matsumoto R, Hirashima M (2002) Regulation of Galectin-9 expression and release in Jurkat T cell line cells. Glycobiology 12:111\u2013118. https:\/\/doi.org\/10.1093\/glycob\/12.2.111","journal-title":"Glycobiology"},{"key":"6029_CR69","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1105\/tpc.16.00043","volume":"28","author":"J Kudla","year":"2016","unstructured":"Kudla J, Bock R (2016) Lighting the way to protein-protein interactions: recommendations on best practices for bimolecular fluorescence complementation analyses. Plant Cell 28:1002\u20131008","journal-title":"Plant Cell"},{"key":"6029_CR70","doi-asserted-by":"publisher","first-page":"70006","DOI":"10.18632\/oncotarget.19549","volume":"8","author":"M Cai","year":"2017","unstructured":"Cai M, Liao Z, Chen T, Wang P, Zou X, Wang Y, Xu Z, Jiang S, Huang J, Chen D et al (2017) Characterization of the subcellular localization of Epstein-Barr virus encoded proteins in live cells. Oncotarget 8:70006\u201370034. https:\/\/doi.org\/10.18632\/oncotarget.19549","journal-title":"Oncotarget"},{"key":"6029_CR71","doi-asserted-by":"publisher","first-page":"444","DOI":"10.3389\/FMICB.2020.00444","volume":"11","author":"AR Mele","year":"2020","unstructured":"Mele AR, Marino J, Dampier W, Wigdahl B, Nonnemacher MR (2020) HIV-1 Tat length: comparative and functional considerations. Front Microbiol 11:444. https:\/\/doi.org\/10.3389\/FMICB.2020.00444","journal-title":"Front Microbiol"},{"key":"6029_CR72","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.3390\/MOLECULES17044047","volume":"17","author":"HC Ishikawa-Ankerhold","year":"2012","unstructured":"Ishikawa-Ankerhold HC, Ankerhold R, Drummen GPC (2012) Advanced fluorescence microscopy techniques\u2014FRAP, FLIP, FLAP, FRET and FLIM. Molecules 17:4047. https:\/\/doi.org\/10.3390\/MOLECULES17044047","journal-title":"Molecules"},{"key":"6029_CR73","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto SKEGG (2000) Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28:27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27","journal-title":"Nucleic Acids Res"},{"key":"6029_CR74","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.3324\/haematol.2017.184192","volume":"103","author":"M de Charette","year":"2018","unstructured":"de Charette M, Houot R (2018) Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy. Haematologica 103:1256\u20131268","journal-title":"Haematologica"},{"key":"6029_CR75","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1200\/JCO.2008.19.6626","volume":"27","author":"T Powles","year":"2009","unstructured":"Powles T, Robinson D, Stebbing J, Shamash J, Nelson M, Gazzard B, Mandelia S, M\u00f8ller H, Bower M (2009) Highly active antiretroviral therapy and the incidence of non\u2013AIDS-defining cancers in people with HIV infection. J Clin Oncol 27:884\u2013890. https:\/\/doi.org\/10.1200\/JCO.2008.19.6626","journal-title":"J Clin Oncol"},{"key":"6029_CR76","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1158\/1055-9965.EPI-14-1079","volume":"24","author":"JL Marcus","year":"2015","unstructured":"Marcus JL, Chao C, Leyden WA, Xu L, Yu J, Horberg MA, Klein D, Towner WJ, Quesenberry CP, Abrams DI et al (2015) Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers. Cancer Epidemiol Biomarkers Prev 24:1167\u20131173. https:\/\/doi.org\/10.1158\/1055-9965.EPI-14-1079","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6029_CR77","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1158\/1055-9965.EPI-16-0964","volume":"26","author":"AE Coghill","year":"2017","unstructured":"Coghill AE, Pfeiffer RM, Shiels MS, Engels EA (2017) Excess mortality among HIV-infected individuals with cancer in the United States. Cancer Epidemiol Biomarkers Prev 26:1027\u20131033. https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-0964","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"6029_CR78","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1080\/14656566.2016.1252332","volume":"17","author":"M Berretta","year":"2016","unstructured":"Berretta M, Di Francia R, Stanzione B, Facchini G, LLeshi A, De Paoli P, Spina M, Tirelli U (2016) New treatment strategies for HIV-positive cancer patients undergoing antiblastic chemotherapy. Expert Opin Pharmacother 17:2391\u20132403. https:\/\/doi.org\/10.1080\/14656566.2016.1252332","journal-title":"Expert Opin Pharmacother"},{"key":"6029_CR79","doi-asserted-by":"publisher","first-page":"866","DOI":"10.7326\/M17-2499","volume":"168","author":"MS Shiels","year":"2018","unstructured":"Shiels MS, Islam JY, Rosenberg PS, Hall HI, Jacobson E, Engels EA (2018) Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the United States through 2030. Ann Intern Med 168:866. https:\/\/doi.org\/10.7326\/M17-2499","journal-title":"Ann Intern Med"},{"key":"6029_CR80","doi-asserted-by":"publisher","first-page":"e495","DOI":"10.1016\/S2352-3018(17)30125-X","volume":"4","author":"RU Hern\u00e1ndez-Ram\u00edrez","year":"2017","unstructured":"Hern\u00e1ndez-Ram\u00edrez RU, Shiels MS, Dubrow R, Engels EA (2017) Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study. Lancet HIV 4:e495\u2013e504. https:\/\/doi.org\/10.1016\/S2352-3018(17)30125-X","journal-title":"Lancet HIV"},{"key":"6029_CR81","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1182\/blood-2014-11-599951","volume":"125","author":"A Arvey","year":"2015","unstructured":"Arvey A, Ojesina AI, Pedamallu CS, Ballon G, Jung J, Duke F, Leoncini L, De Falco G, Bressman E, Tam W et al (2015) The tumor virus landscape of AIDS-related lymphomas. Blood 125:e14\u2013e22. https:\/\/doi.org\/10.1182\/blood-2014-11-599951","journal-title":"Blood"},{"key":"6029_CR82","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3390\/cancers13020305","volume":"13","author":"M Isaguliants","year":"2021","unstructured":"Isaguliants M, Bayurova E, Avdoshina D, Kondrashova A, Chiodi F, Palefsky JM (2021) Oncogenic effects of HIV-1 proteins, mechanisms behind. Cancers (Basel) 13:305. https:\/\/doi.org\/10.3390\/cancers13020305","journal-title":"Cancers (Basel)"},{"key":"6029_CR83","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1038\/leu.2017.106","volume":"31","author":"D Germini","year":"2017","unstructured":"Germini D, Tsfasman T, Klibi M, El-Amine R, Pichugin A, Iarovaia OV, Bilhou-Nabera C, Subra F, Bou Saada Y, Sukhanova A et al (2017) HIV Tat induces a prolonged MYC relocalization next to IGH in circulating B-cells. Leukemia 31:2515\u20132522. https:\/\/doi.org\/10.1038\/leu.2017.106","journal-title":"Leukemia"},{"key":"6029_CR84","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1038\/emboj.2010.32","volume":"29","author":"F Rayne","year":"2010","unstructured":"Rayne F, Debaisieux S, Yezid H, Lin Y-L, Mettling C, Konate K, Chazal N, Arold ST, Pugni\u00e8re M, Sanchez F et al (2010) Phosphatidylinositol-(4,5)-bisphosphate enables efficient secretion of HIV-1 Tat by infected T-cells. EMBO J 29:1348\u20131362. https:\/\/doi.org\/10.1038\/emboj.2010.32","journal-title":"EMBO J"},{"key":"6029_CR85","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.yexcr.2004.01.018","volume":"295","author":"E Colombrino","year":"2004","unstructured":"Colombrino E, Rossi E, Ballon G, Terrin L, Indraccolo S, Chieco-Bianchi L, De Rossi A (2004) Human immunodeficiency virus type 1 Tat protein modulates cell cycle and apoptosis in Epstein\u2013Barr virus-immortalized B cells. Exp Cell Res 295:539\u2013548. https:\/\/doi.org\/10.1016\/j.yexcr.2004.01.018","journal-title":"Exp Cell Res"},{"key":"6029_CR86","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1089\/088922201750290087","volume":"17","author":"V Cantaluppi","year":"2001","unstructured":"Cantaluppi V, Biancone L, Boccellino M, Doublier S, Benelli R, Carlone S, Albini A, Camussi G (2001) HIV type 1 Tat protein is a survival factor for Kaposi\u2019s sarcoma and endothelial cells. AIDS Res Hum Retroviruses 17:965\u2013976. https:\/\/doi.org\/10.1089\/088922201750290087","journal-title":"AIDS Res Hum Retroviruses"},{"key":"6029_CR87","doi-asserted-by":"publisher","DOI":"10.1186\/1756-9966-27-3","volume":"27","author":"G Nunnari","year":"2008","unstructured":"Nunnari G, Smith JA, Daniel R (2008) HIV-1 tat and AIDS-associated cancer: targeting the cellular anti-cancer barrier? J Exp Clin Cancer Res 27:3. https:\/\/doi.org\/10.1186\/1756-9966-27-3","journal-title":"J Exp Clin Cancer Res"},{"key":"6029_CR88","doi-asserted-by":"publisher","first-page":"684","DOI":"10.4161\/cbt.5.6.2907","volume":"5","author":"J Nyagol","year":"2006","unstructured":"Nyagol J, Leucci E, Onnis A, De Falco G, Tigli C, Sanseverino F, Torriccelli M, Palummo N, Pacenti L, Santopietro R et al (2006) The effects of HIV-1 Tat protein on cell cycle during cervical carcinogenesis. Cancer Biol Ther 5:684\u2013690","journal-title":"Cancer Biol Ther"},{"key":"6029_CR89","doi-asserted-by":"publisher","first-page":"e13986","DOI":"10.7717\/peerj.13986","volume":"10","author":"AA Valyaeva","year":"2022","unstructured":"Valyaeva AA, Tikhomirova MA, Potashnikova DM, Bogomazova AN, Snigiryova GP, Penin AA, Logacheva MD, Arifulin EA, Shmakova AA, Germini D et al (2022) Ectopic expression of HIV-1 Tat modifies gene expression in cultured B cells: implications for the development of B-Cell lymphomas in HIV-1-infected patients. PeerJ 10:e13986. https:\/\/doi.org\/10.7717\/peerj.13986","journal-title":"PeerJ"},{"key":"6029_CR90","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.redox.2017.11.024","volume":"15","author":"R El-Amine","year":"2018","unstructured":"El-Amine R, Germini D, Zakharova VV, Tsfasman T, Sheval EV, Louzada RAN, Dupuy C, Bilhou-Nabera C, Hamade A, Najjar F et al (2018) HIV-1 Tat protein induces DNA damage in human peripheral blood B-lymphocytes via mitochondrial ROS production. Redox Biol 15:97\u2013108. https:\/\/doi.org\/10.1016\/j.redox.2017.11.024","journal-title":"Redox Biol"},{"key":"6029_CR91","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/157016207781023974","volume":"5","author":"D Huynh","year":"2007","unstructured":"Huynh D, Vincan E, Mantamadiotis T, Purcell D, Chan C-K, Ramsay R (2007) Oncogenic properties of HIV-Tat in colorectal cancer cells. Curr HIV Res 5:403\u2013409","journal-title":"Curr HIV Res"},{"key":"6029_CR92","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1091\/mbc.12.10.2934","volume":"12","author":"E Toschi","year":"2001","unstructured":"Toschi E, Barillari G, Sgadari C, Bacigalupo I, Cereseto A, Carlei D, Palladino C, Zietz C, Leone P, St\u00fcrzl M et al (2001) Activation of Matrix-Metalloproteinase-2 and Membrane-Type-1-Matrix-Metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor. Mol Biol Cell 12:2934\u20132946. https:\/\/doi.org\/10.1091\/mbc.12.10.2934","journal-title":"Mol Biol Cell"},{"key":"6029_CR93","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.3390\/cells12182312","volume":"12","author":"OK Szewczyk-Roszczenko","year":"2023","unstructured":"Szewczyk-Roszczenko OK, Roszczenko P, Shmakova A, Finiuk N, Holota S, Lesyk R, Bielawska A, Vassetzky Y, Bielawski K (2023) The chemical inhibitors of endocytosis: from mechanisms to potential clinical applications. Cells 12:2312. https:\/\/doi.org\/10.3390\/cells12182312","journal-title":"Cells"},{"key":"6029_CR94","doi-asserted-by":"publisher","first-page":"C404","DOI":"10.1152\/ajpcell.00723.2024","volume":"328","author":"OK Szewczyk-Roszczenko","year":"2025","unstructured":"Szewczyk-Roszczenko OK, Roszczenko P, Shmakova A, Yushyn I, Holota S, Karpenko O, Czarnomysy R, Bielawska A, Vassetzky Y, Lesyk R et al (2025) Novel endocytosis inhibitors block entry of HIV-1 Tat into neural cells. Am J Physiol Cell Physiol 328:C404\u2013C413. https:\/\/doi.org\/10.1152\/ajpcell.00723.2024","journal-title":"Am J Physiol Cell Physiol"},{"key":"6029_CR95","doi-asserted-by":"publisher","first-page":"e01280","DOI":"10.1128\/JVI.01280-19","volume":"94","author":"W-S Yang","year":"2020","unstructured":"Yang W-S, Lin T-Y, Chang L, Yeh WW, Huang S-C, Chen T-Y, Hsieh Y-T, Chen S-T, Li W-C, Pan C-C et al (2020) HIV-1 Tat interacts with a kaposi\u2019s Sarcoma-Associated herpesvirus Reactivation-Upregulated antiangiogenic long noncoding RNA, LINC00313, and antagonizes its function. J Virol 94:e01280\u2013e01219. https:\/\/doi.org\/10.1128\/JVI.01280-19","journal-title":"J Virol"},{"key":"6029_CR96","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/ijc.29494","volume":"137","author":"D Martorelli","year":"2015","unstructured":"Martorelli D, Muraro E, Mastorci K, Dal Col J, Fa\u00e8 DA, Furlan C, Giagulli C, Caccuri F, Rusnati M, Fiorentini S et al (2015) A natural HIV P17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting. Int J Cancer 137:1374\u20131385. https:\/\/doi.org\/10.1002\/ijc.29494","journal-title":"Int J Cancer"},{"key":"6029_CR97","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.1128\/JVI.64.12.6282-6285.1990","volume":"64","author":"R Mallon","year":"1990","unstructured":"Mallon R, Borkowski J, Albin R, Pepitoni S, Schwartz J, Kieff E (1990) The Epstein-Barr virus BZLF1 gene product activates the human immunodeficiency virus type 1 5\u2019 long terminal repeat. J Virol 64:6282\u20136285. https:\/\/doi.org\/10.1128\/JVI.64.12.6282-6285.1990","journal-title":"J Virol"},{"key":"6029_CR98","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.8493575","volume":"260","author":"TK Howcroft","year":"1993","unstructured":"Howcroft TK, Strebel K, Martin MA, Singer DS (1993) Repression of MHC class I gene promoter activity by two-exon Tat of HIV. Science 260:1320\u20131322. https:\/\/doi.org\/10.1126\/science.8493575","journal-title":"Science"},{"key":"6029_CR99","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1128\/JVI.02183-15","volume":"90","author":"LL Quinn","year":"2015","unstructured":"Quinn LL, Williams LR, White C, Forrest C, Zuo J, Rowe M (2015) The missing link in Epstein-Barr virus immune evasion: the BDLF3 gene induces ubiquitination and downregulation of major histocompatibility complex class I (MHC-I) and MHC-II. J Virol 90:356\u2013367. https:\/\/doi.org\/10.1128\/JVI.02183-15","journal-title":"J Virol"},{"key":"6029_CR100","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1093\/emboj\/21.10.2418","volume":"21","author":"EW Hewitt","year":"2002","unstructured":"Hewitt EW, Duncan L, Mufti D, Baker J, Stevenson PG, Lehner PJ (2002) Ubiquitylation of MHC class I by the K3 viral protein signals internalization and TSG101-dependent degradation. EMBO J 21:2418\u20132429. https:\/\/doi.org\/10.1093\/emboj\/21.10.2418","journal-title":"EMBO J"},{"key":"6029_CR101","doi-asserted-by":"publisher","unstructured":"Buschle A, Mrozek-Gorska P, Krebs S, Blum H, Cernilogar F, Schotta G, Pich D, Straub T, Hammerschmidt W (2019) Epstein-Barr Virus Inactivates the Transcriptome and Disrupts the Chromatin Architecture of Its Host Cell in the First Phase of Lytic Reactivation. bioRxiv 573659. https:\/\/doi.org\/10.1101\/573659","DOI":"10.1101\/573659"},{"key":"6029_CR102","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00281-020-00792-2","volume":"42","author":"A Buschle","year":"2020","unstructured":"Buschle A, Hammerschmidt W (2020) Epigenetic lifestyle of Epstein-Barr virus. Semin Immunopathol 42:131\u2013142","journal-title":"Semin Immunopathol"},{"key":"6029_CR103","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.64.3.1227-1232.1990","author":"E Flemington","year":"1990","unstructured":"Flemington E, Speck SH (1990) Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J Virol. https:\/\/doi.org\/10.1128\/JVI.64.3.1227-1232.1990","journal-title":"J Virol"},{"key":"6029_CR104","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.it.2014.01.003","volume":"35","author":"AB Rickinson","year":"2014","unstructured":"Rickinson AB, Long HM, Palendira U, M\u00fcnz C, Hislop AD (2014) Cellular immune controls over Epstein-Barr virus infection: new lessons from the clinic and the laboratory. Trends Immunol 35:159\u2013169. https:\/\/doi.org\/10.1016\/j.it.2014.01.003","journal-title":"Trends Immunol"},{"key":"6029_CR105","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","volume":"25","author":"AD Hislop","year":"2007","unstructured":"Hislop AD, Taylor GS, Sauce D, Rickinson AB (2007) Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 25:587\u2013617. https:\/\/doi.org\/10.1146\/annurev.immunol.25.022106.141553","journal-title":"Annu Rev Immunol"},{"key":"6029_CR106","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","volume":"33","author":"GS Taylor","year":"2015","unstructured":"Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD (2015) The immunology of Epstein-Barr virus-induced disease. Annu Rev Immunol 33:787\u2013821. https:\/\/doi.org\/10.1146\/annurev-immunol-032414-112326","journal-title":"Annu Rev Immunol"},{"key":"6029_CR107","doi-asserted-by":"publisher","first-page":"e81635","DOI":"10.1371\/journal.pone.0081635","volume":"8","author":"PD Burbelo","year":"2013","unstructured":"Burbelo PD, Ching KH, Morse CG, Alevizos I, Bayat A, Cohen JI, Ali MA, Kapoor A, Browne SK, Holland SM et al (2013) Altered antibody profiles against common infectious agents in chronic disease. PLoS One 8:e81635. https:\/\/doi.org\/10.1371\/journal.pone.0081635","journal-title":"PLoS One"},{"key":"6029_CR108","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3389\/fmicb.2013.00311","volume":"4","author":"MR Petrara","year":"2013","unstructured":"Petrara MR, Freguja R, Gianesin K, Zanchetta M, De Rossi A (2013) Epstein-Barr virus-driven lymphomagenesis in the context of human immunodeficiency virus type 1 infection. Front Microbiol 4:311. https:\/\/doi.org\/10.3389\/fmicb.2013.00311","journal-title":"Front Microbiol"},{"key":"6029_CR109","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/00002030-200201040-00009","volume":"16","author":"E Righetti","year":"2002","unstructured":"Righetti E, Ballon G, Ometto L, Cattelan AM, Menin C, Zanchetta M, Chieco-Bianchi L, De Rossi A (2002) Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy. AIDS 16:63\u201373. https:\/\/doi.org\/10.1097\/00002030-200201040-00009","journal-title":"AIDS"},{"key":"6029_CR110","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1172\/JCI119315","volume":"99","author":"MJ Kersten","year":"1997","unstructured":"Kersten MJ, Klein MR, Holwerda AM, Miedema F, van Oers MH (1997) Epstein-barr virus-specific cytotoxic T cell responses in HIV-1 infection: different kinetics in patients progressing to opportunistic infection or non-hodgkin\u2019s lymphoma. J Clin Invest 99:1525\u20131533","journal-title":"J Clin Invest"},{"key":"6029_CR111","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1295202","volume":"6","author":"M Nijland","year":"2017","unstructured":"Nijland M, Veenstra RN, Visser L, Xu C, Kushekhar K, van Imhoff GW, Kluin PM, van den Berg A, Diepstra A (2017) HLA dependent immune escape mechanisms in B-cell lymphomas: implications for immune checkpoint inhibitor therapy? Oncoimmunology 6:e1295202. https:\/\/doi.org\/10.1080\/2162402X.2017.1295202","journal-title":"Oncoimmunology"},{"key":"6029_CR112","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.3324\/haematol.2017.184192","volume":"103","author":"M de Charette","year":"2018","unstructured":"de Charette M, Houot R (2018) Hide or defend, the two strategies of lymphoma immune evasion: potential implications for immunotherapy. Haematologica 103:1256\u20131268. https:\/\/doi.org\/10.3324\/haematol.2017.184192","journal-title":"Haematologica"},{"key":"6029_CR113","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.4049\/jimmunol.175.3.2010","volume":"175","author":"E Piriou","year":"2005","unstructured":"Piriou E, Jansen CA, van Dort K, De Cuyper I, Nanlohy NM, Lange JMA, van Oers MHJ, Miedema F, van Baarle D (2005) Reconstitution of EBV latent but not lytic antigen-specific CD4\u2009+\u2009and CD8\u2009+\u2009T cells after HIV treatment with highly active antiretroviral therapy. J Immunol 175:2010\u20132017. https:\/\/doi.org\/10.4049\/jimmunol.175.3.2010","journal-title":"J Immunol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-06029-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-06029-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-06029-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T04:13:45Z","timestamp":1770264825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-06029-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,2]]},"references-count":113,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6029"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-06029-5","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,2]]},"assertion":[{"value":"20 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Whole blood samples from anonymous healthy donors of different sex and age were obtained from the \u201cEtablissment Fran\u00e7ais du Sang\u201d, H\u00f4pital Saint-Louis, Paris, France in accordance with the French legislation (agreement number \u2116 14\/EFS\/033). Blood samples from HIV-positive individuals who signed a written informed consent for the study and were treated at the Clinical Hospital \u2116 67, Moscow, Russia or Department of Clinical Immunology, H\u00f4pital Saint-Louis, Paris, France (agreement VIHEBV), were collected in accordance with the Russian or French legislation, respectively.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors consent to publish the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report there are no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}